The downregulation of Beclin‐1 has been linked to the environmental adaptation of cancer cells, allowing them to reprogram glucose metabolism and proliferate; however, it can also be upregulated depending on tumor type.[85, 86, 87]. The gene discussed is BECN1; the disease is cancer.